QART Medical, founded by Prof Natan Shaked finalizes round of venture investment
Breakthrough solution for highly informative characterization and selection of sperm cells for IVF
QART (Quantitative Assisted Reproductive Technologies) Medical, a clinical-stage MedTech company, addressing the global infertility epidemic. The Company develops a breakthrough solution for highly informative characterization and selection of sperm cells for in-vitro fertilization (IVF), aiming to create a new and better gold standard in the ART market. The QART system aims to improve current success rates of Intra-Cytoplasmic Sperm Injection
Prof. Natan T. Shaked is associate Professor in the Department of Biomedical Engineering at Tel Aviv University. Between April 2011-July 2015, he was a Senior Lecturer (Assistant Professor) in the same department. Previously, Prof. Shaked was a Visiting Assistant Professor in the Department of Biomedical Engineering at Duke University, Durham, North Carolina, USA. Prof. Shaked heads the Biomedical Optical Microscopy, Nanoscopy and Interferometry Research Group, a large experimental group performing a multidisciplinary research involving optical engineering, imaging and sensing in biological systems, optical therapy, and biophysics. Specific interests of research include: biomedical optical microscopy and nanoscopy, optical interferometric systems (including interferometric phase microscopy and optical coherence tomography), optical imaging and therapy using nano-particles in biological cells, optical signatures of cancer and fertility problems, and three-dimensional optical imaging and holography for biomedical applications.